The independent medical news service
Head and neck cancer
21-10-2021 | Oncology | News | Article
Hearing loss protection recommendations made for paediatric CNS, head and neck cancer patients
The risk of high-frequency hearing loss in children undergoing cancer treatment to the central nervous system or the head and neck could be reduced by minimising doses of radiation to the cochlea and limiting cumulative doses of cisplatin or carboplatin, Canadian researchers say.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
04-05-2018 | Oncology | News | Article
In other news
This month we bring you a round-up of four trials investigating nivolumab in diverse tumors, including non-small-cell lung cancer, Hodgkin lymphoma, and nasopharyngeal carcinoma. Read on to find out more.
06-04-2018 | Oncology | News | Article
In other news
In this month’s roundup, we cover topics including laboratory eligibility criteria as a potential barrier to clinical participation and the impact of cognitive dysfunction on survival in patients with hematologic cancers. Read on to find out more.